Skip to main content
John Crary, MD, Pathology, New York, NY, The Mount Sinai Hospital

JohnCraryMD

Pathology New York, NY

Neuropathology, Anatomic Pathology, Clinical Pathology

Associate Professor, Icahn School of Medicine at Mount Sinai

Dr. Crary is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Crary's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuropathology, 2008 - 2010
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 2006 - 2008
  • SUNY Downstate Medical Center
    SUNY Downstate Medical CenterPh.D., Neural & behavioral science, 1997 - 2006
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2006
  • Brown University
    Brown UniversitySc.B., Neuroscience, with Honors, 1992 - 1996

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2008 - 2025
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Neuropathology

Awards, Honors, & Recognition

  • Alexander Saint-Amand Scholar 2016
  • Louis V. Gerstner, Jr. Scholar 2011
  • SUNY Chancellor’s Award for Student Excellence 2006
  • Join now to see all

Publications & Presentations

PubMed

Lectures

  • Tautologies & Tau 
    University of California San Diego - 1/1/2017
  • Age-related tauopathy: Clinical, genetic and molecular studies. 
    1/1/2017
  • Refining the neuropathological criteria for Alzheimer's disease 
    New York, NY - 1/1/2016
  • Join now to see all

Press Mentions

  • Mount Sinai Researchers Use Artificial Intelligence to Uncover the Cellular Origins of Alzheimer’s Disease and Other Cognitive Disorders
    Mount Sinai Researchers Use Artificial Intelligence to Uncover the Cellular Origins of Alzheimer’s Disease and Other Cognitive DisordersSeptember 20th, 2022
  • AI Platform Shows Potential in Diagnosing Patients at Early Stages
    AI Platform Shows Potential in Diagnosing Patients at Early StagesApril 28th, 2022
  • PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s Disease
    PreciseDx’s AI-Enabled Digital Pathology Proven to Detect Early-Stage Parkinson’s DiseaseApril 20th, 2022
  • Join now to see all

Grant Support

  • : Regulation of tau expression in Alzheimer disease and agingNIH/NIA2016–2021
  • Mechanisms of age-related tauopathyNIH/NIA2015–2020
  • Clinical-Pathological Study of Cognitive Impairment in ETNIH/NINDS2014–2019
  • Molecular & genetic investigation of tau in CTEDepartment of Defense2014–2019
  • Aptamer-based bioactuators for early diagnosis of ADSaint-Amand Research Scholar Award2016–2017
  • Career Development in the Neuropathology of ADNIH/NIA2015–2017
  • Regulation of tau expression and toxicity by miR-219Rainwater Foundation2015–2017
  • Neuropathological characterization of PARTAlzheimer's Association2015–2017

Hospital Affiliations